Satio

Founded with the mission to revolutionize blood collection, Satio focuses on creating simple, painless, and clean patch technology for dried blood spot and whole blood collection. Their innovative products are designed to transform healthcare workflows by offering rapid and affordable detection, prevention, and treatment solutions. Satio primarily targets patients seeking convenient at-home options and those facing challenges in accessing medical services.

Notable figures associated with Satio include key investors and advisors from the healthcare and technology sectors. The company has achieved significant milestones, including the development of patent-pending products that promise to streamline blood collection processes. Although their products are still under review by the FDA and other notified bodies, Satio's impact lies in its potential to make blood collection more accessible and efficient for a broad range of patients.